Base excision repair in the immune system: small DNA lesions with big consequences

M Stratigopoulou, TP van Dam… - Frontiers in …, 2020 - frontiersin.org
The integrity of the genome is under constant threat of environmental and endogenous
agents that cause DNA damage. Endogenous damage is particularly pervasive, occurring at …

Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing

F Davi, AW Langerak, AL de Septenville, PM Kolijn… - Leukemia, 2020 - nature.com
Twenty years after landmark publications, there is a consensus that the somatic
hypermutation (SHM) status of the clonotypic immunoglobulin heavy variable (IGHV) gene is …

[HTML][HTML] 3D bioprinting allows the establishment of long-term 3D culture model for chronic lymphocytic leukemia cells

FV Sbrana, R Pinos, F Barbaglio, D Ribezzi… - Frontiers in …, 2021 - frontiersin.org
Chronic Lymphocytic Leukemia (CLL) represents the most common leukemia in the western
world and remains incurable. Leukemic cells organize and interact in the lymphoid tissues …

Pharmacological modulation of Kv1. 3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model

F Severin, A Urbani, T Varanita, M Bachmann… - Journal of Experimental …, 2022 - Springer
Background Ion channels are emerging as promising oncological targets. The potassium
channels Kv1. 3 and IKCa are highly expressed in the plasma membrane and mitochondria …

Convergent evolution and B-cell recirculation in germinal centers in a human lymph node

A Pelissier, M Stratigopoulou, N Donner… - Life Science …, 2023 - life-science-alliance.org
Germinal centers (GCs) play a central role in generating an effective immune response
against infectious pathogens, and failures in their regulating mechanisms can lead to the …

An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies

S Khan, D Allsup, S Molica - Frontiers in Oncology, 2023 - frontiersin.org
Chronic lymphocytic leukaemia (CLL) is a malignancy of clonally expanded antigen-
switched, neoplastic, mature B cells. CLL is characterised by a variable degree of …

Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from lupus

M Radic, I Neeli, T Marion - Expert Opinion on Biological Therapy, 2022 - Taylor & Francis
Introduction Medicine stands at the threshold of a new era heralded by the vast potential of
cell engineering. Like advances made possible by genetic engineering, current prospects …

Understanding monoclonal B cell lymphocytosis: an interplay of genetic and microenvironmental factors

C Galigalidou, L Zaragoza-Infante, A Iatrou… - Frontiers in …, 2021 - frontiersin.org
The term monoclonal B-cell lymphocytosis (MBL) describes the presence of a clonal B cell
population with a count of less than 5× 109/L and no symptoms or signs of disease. Based …

Chronic lymphocytic leukemia (CLL) with borderline immunoglobulin heavy chain mutational status, a rare subgroup of CLL with variable disease course

F Angotzi, A Cellini, V Ruocco, CA Cavarretta, I Zatta… - Cancers, 2024 - mdpi.com
Simple Summary In this study, we present a retrospective analysis of a large cohort of CLL
patients with a particular focus on those with a borderline immunoglobulin heavy variable …

Immunogenetics in hematopathology and hematology: why a common language is important

K Stamatopoulos, E Bruford, E Campo, MP Lefranc - Leukemia, 2024 - nature.com
A defining feature of the immune system concerns the generation of a remarkably diverse
repertoire of antigen-specific lymphocytes, each carrying a unique antigen receptor: the …